Cinnarizone self micro emulsified soft capsule and its preparation method

A self-micro-emulsifying, cinnarizine technology, applied in the field of medicine, can solve the problems of reduced bioavailability and reduced drug dissolution, and achieve the effects of reducing individual differences, improving curative effect, and improving bioavailability

Inactive Publication Date: 2004-12-22
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Existing oral preparations of cinnarizine have preparations such as tablets and hard capsules. According to foreign literature reports, the bioavailability of cinnarizine depends on its dissolved amount in the stomach, and the gastric acidity of people is affected by food or physiological factors. The effect o

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cinnarizone self micro emulsified soft capsule and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0032] Example 1:

[0033] The composition of the prescription is as follows: (g)

[0034] Cinnarizine 25

[0035] Dimethyl isosorbide 100

[0036] Oleic acid 50

[0037] Tween 80 185

[0038] Vitamin E 5

[0039] A total of 1000 soft capsules

[0040] Preparation process: Cinnarizine self-microemulsifying capsules Preparation method: Weigh an appropriate amount of cinnarizine, add the prescription amount of dimethyl isosorbide, Tween 80, and oleic acid, in a constant temperature shaking bath at 40C, 100 rpm Shake for about 1.5 hours to dissolve, then add antioxidants and stir evenly. After the liquid drops to room temperature, press to form a capsule.

[0041] The dissolution rate of the cinnarizine self-microemulsifying capsules prepared according to Example 1 was compared with commercially available tablets and capsules: the prepared homogeneous solution was filled into hard capsules according to the prescription amount, and the commercially available cinnarizi...

Example Embodiment

[0044] Example 2:

[0045] The composition of the prescription is as follows: (g)

[0046] Cinnarizine 25

[0047] Dimethyl isosorbide 130

[0048] Oleic acid 55

[0049] Tween 80 185

[0050] Vitamin E 5

[0051] A total of 1000 soft capsules

[0052] The preparation process is the same as in Example 1.

Example Embodiment

[0053] Example 3:

[0054] The composition of the prescription is as follows: (g)

[0055] Cinnarizine 25

[0056] Dimethyl isosorbide 150

[0057] Oleic acid 38

[0058] Tween 80 190

[0059] Vitamin E 5

[0060] A total of 1000 soft capsules

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A self-microemulsified softgel of cinnarizine for treating cerebral infarction, cerebral arteriosclerosis, cerebral trauma sequelae, etc is prepared from cannarizine, coemulsifier, emulsifier and an oil phase through proportionally mixing, and stirring while self emulsifying. Its advantage is high biological utilization rate.

Description

Technical field: [0001] The invention relates to the technical field of medicine, in particular to a cinnarizine self-microemulsified soft capsule and a preparation method thereof. Background technique: [0002] Cinnarizine is a piperazine calcium channel blocker, which can block the calcium inflow of vascular smooth muscle, cause vasodilation, and can significantly improve cerebral circulation and coronary circulation. Vasospasm. The duration of action is also very long. It is mainly used for cerebral arteriosclerosis, cerebral infarction, hypertensive encephalopathy, cerebral thrombosis, cerebral hemorrhage recovery period and subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo and peripheral vascular diseases such as Raynaud's disease, etc. Also used for tinnitus, dizziness and hearing impairment. [0003] Cinnarizine has antihistamine, anti-serotonin, antikinin activities and inhibits complement C 4 The role of activation. It has cer...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/48A61K31/495A61P9/10A61P9/12A61P17/00
Inventor 何仲贵殷静唐星张天虹
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap